IMRX
Immuneering Corp
$5.19
+0.14 (+2.77%)
At close · Jul 2
Market Cap
$335.78M
Shares
64,697,402
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-06-01 | Atebimetinib ASCO Data Update in 1L Pancreatic Cancer | Event |
| 2026-04-13 | 25th Annual Needham Virtual Healthcare Conference | Conference |
| 2026-03-09 | Leerink Global Healthcare Conference | Conference |
| 2026-02-26 | Oppenheimer 36th Annual Healthcare Life Sciences Conference | Conference |
| 2026-01-07 | Atebimetinib Updated 12-mth Overall Survival Data in 1L Pancreatic Cancer | Event |
| 2025-12-04 | Piper Sandler 37th Annual Healthcare Conference | Conference |
| 2025-11-12 | Q3 2025 Immuneering Corporation Earnings Conference Call | Earnings call |
| 2025-09-29 | Phase 2a Data Update for IMM-1-104 in First-Line Pancreatic Cancer | Event |
Source: https://ir.immuneering.com/